Gedeon, Richter

Gedeon Richter : la cariprazine a de réelles chances de devenir le médicament antipsychotique atypique le plus vendu

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Gedeon Richter Plc. Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom Hungary United States of America

View original content:https://www.prnewswire.com/news-releases/gedeon-richter--la-cariprazine-a-de-reelles-chances-de-devenir-le-medicament-antipsychotique-atypique-le-plus-vendu-302113067.html

en | boerse | 67927650 |